January 2, 2014 10:36 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Oramed Pharmaceuticals (NASDAQ: ORMP) shares moved up 15.68% to $17.85. The volume of Oramed Pharmaceuticals shares traded was 971% higher than normal. Oramed received patent allowance in Israel, Australia for platform technology in oral delivery of proteins.PhotoMedex (NASDAQ: PHMD) shares rose 2.47% to $13.27. The volume of PhotoMedex shares traded was 659% higher than normal. PhotoMedex lifted its Q4 revenue forecast.Kandi Technolgies Group (NASDAQ: KNDI) shares climbed 13.06% to $13.33. The volume of Kandi Technolgies shares traded was 333% higher than normal. Kandi Technolgies shares have jumped 198.48% over the past 52 weeks, while the S&P 500 index has gained 26.39% in the same period.Crocs (NASDAQ: CROX) surged 5.40% to $16.78. The volume of Crocs shares traded was 191% higher than normal. Monness Crespi Hardt upgraded Crocs from Neutral to Buy.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.